PharmAccess
Tobias Rinke de Wit has extensive experience in global health and development. Tobias is currently working as a Research Director at the Joep Lange Institute since 2018. Prior to that, they held the position of Professor at the Amsterdam Institute for Global Health and Development, where they conducted research on infectious diseases in Africa. Tobias focused on topics such as the roll-out of HIV treatment programs, HIV drug resistance, community-based HIV monitoring, HIV diagnostics, and epidemiology. In addition, Tobias was the Director of Research & Learning at the PharmAccess Foundation, where they were responsible for soliciting and coordinating research on the effectiveness of PharmAccess interventions in various disciplines such as social sciences, economics, clinical and epidemiological research, and market research.
Tobias Rinke de Wit obtained their PhD in Molecular Biology from Leiden University in the period from 1979 to 1991. The details about their start and end year are not provided for their professorship, but they became a Professor in Global Health at the University of Amsterdam starting from 2005.
This person is not in any teams
This person is not in any offices
PharmAccess
PharmAccess is an international NGO that believes in doing healthcare better. Focusing on sub-Saharan Africa, we work to improve healthcare markets so they deliver for all so people can access better care, live healthier lives, and reach their full potential. With headquarters in Amsterdam and most of its staff based in four country offices across Africa, PharmAccess is an international NGO with a history of reimagining what is possible. We challenge the notion that exclusion from healthcare is an inevitable consequence of living in poorer countries and identify the opportunities and partners – both private and public, needed to bring about transformation. This means mobilizing private and public resources, measuring and improving quality of services, and reaching even the most excluded people with financing options to pay for care. This approach was instilled by our founder Dr Joep Lange, a world leading aids researcher who went against the status quo in 2001 when he proved that working with the private sector could play a critical role in delivering life-saving antiretroviral therapy for HIV/AIDS treatment in Africa. PharmAccess has since evolved to embrace other opportunities for inclusive healthcare, with a particular focus on what the digital revolution can deliver. PharmAccess aims to be an innovator and catalyst for practical changes that can be scaled up. Initiatives such as SafeCare equip healthcare providers with clinical standards for quality improvement that investors and patients can trust. The Medical Credit Fund drives more money into the system - it offers loans to clinics to stimulate growth and encourage new ways of financing healthcare. We use mobile health platforms to develop a new model to make healthcare work for everyone. PharmAccess believes that better functioning healthcare markets are key to advancing a number of the Sustainable Development Goal’s, in particular the targets relating to the realization of Universal Health Coverage.